美国养老院居民潜在药物相互作用的发生率与持续时间(2018-2020)
这项队列研究基于2018至2020年Medicare理赔数据与Minimum Data Set 3.0临床评估,纳入485,251名年龄≥66岁的养老院居民。结果显示61.6%的居民至少经历一种潜在药物相互作用,最常见者为同时使用≥3种中枢神经系统活性药物(27.1%)。乙酰胆碱酯酶抑制剂与减慢心率药物联用的中位暴露时间最长(81天)。
要点
- 近三分之二养老院居民暴露于潜在药物相互作用。
- 最常见DDI为同时使用≥3种中枢神经系统活性药物。
- 乙酰胆碱酯酶抑制剂与减慢心率药联用中位暴露81天。
核心结论
- 近三分之二养老院居民暴露于与潜在药物相互作用相关的药物组合,但各DDI的暴露率和持续时间存在差异。
研究设计与样本
- 队列研究,纳入2018至2020年美国养老院中年龄≥66岁的Medicare按服务付费受益人,共485,251人,累计272,780人年。
主要发现
- 61.6%的居民在观察期间经历至少一种潜在DDI。
- 最常见的12种DDI涉及中枢神经系统活性药物、抗胆碱能药、降压药、阿片类和利尿剂。
- 同时使用≥3种中枢神经系统活性药物的DDI最常见,见于27.1%(95% CLs,27.0%,27.2%)的居民。
- 乙酰胆碱酯酶抑制剂与减慢心率药物联用的中位暴露持续时间最长,为81天(Q1-Q3,24-235)。
关键数值与推荐
- 评估了98种潜在DDI,来源于三份专家共识出版物。
- DDI暴露定义为口服药物同时使用≥1天。
临床怎么用
- 老年医学科医生应关注养老院居民中中枢神经系统活性药物、抗胆碱能药、降压药、阿片类和利尿剂的联合使用。
- 对乙酰胆碱酯酶抑制剂与减慢心率药物联用等长暴露组合,可考虑定期评估继续使用的必要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nursing home (NH) residents are at increased risk of drug-drug interactions (DDIs) due to multimorbidity and polypharmacy. While prior research suggests that many DDIs lead to adverse drug events in older adults, the extent of exposure to potentially clinically relevant DDIs among United States (US) NH residents is largely unknown. METHODS: In this cohort study, we calculated the prevalence and duration of exposure to 98 potential DDIs among US NH residents from 2018 to 2020. DDIs were sourced from three expert consensus publications, some of which defined similar interactions and overlapping drug combinations, allowing comparisons within and across lists. Data were drawn from Medicare claims linked to Minimum Data Set 3.0 clinical assessments. Eligible residents included Medicare Fee-for-Service beneficiaries aged ≥ 66 years living in NHs with observable Part D prescription drug data. DDI exposure was defined as ≥ 1 day of concurrent use of orally administered medications. Prevalence was calculated as the proportion of residents exposed to each DDI; duration was measured as the median number of days residents concurrently used the medications of interest. RESULTS: Among 485,251 NH residents, 61.6% experienced ≥ 1 potential DDI over 272,780 person-years. The 12 most prevalent DDIs involved central nervous system (CNS)-active drugs, anticholinergics, antihypertensives, opioids, and diuretics. Of these DDIs, concurrent use of acetylcholinesterase inhibitors and heart rate-reducing drugs had the longest median exposure duration (81 days; Q1-Q3, 24-235). The most prevalent DDI, concomitant use of ≥ 3 CNS-active drugs, was observed in 27.1% (95% CLs, 27.0%, 27.2%) of residents. CONCLUSIONS: Nearly two-thirds of NH residents were exposed to medication combinations linked to potential DDIs, although the prevalence and duration of exposure associated with individual DDIs varied. Future research should determine which DDIs are most clinically significant and investigate barriers to reducing exposure duration in this high-risk population.
引用
- Reich LA, Daiello LA, Berry SD, et al. Prevalence and Duration of Potential Drug-Drug Interactions Among US Nursing Home Residents, 2018-2020. J Am Geriatr Soc. 2025. PMID: 41103191. doi:10.1111/jgs.70175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。